Top

States Try to Obscure Execution Details as Drugmakers Hinder Lethal Injection

Merck signs $922m deal with Opko Health unit for Epstein-Barr vaccine candidate

After Capping Insulin Copays, Colorado Sets Its Sights on EpiPens

Almond, Soy Drinks Can Be Called Milk, FDA Proposes

GSK and Vir Biotech amend COVID-19 research partnership

Tag: 3 VISION trial

FDA, Regulations

FDA approves Novartis’ Pluvicto for prostate cancer

March 24, 2022

Via: PMLiVE

The approval is based on the results of the phase 3 VISION trial that evaluated the effectiveness and safety profile of the drug. Patients involved in the trial who were treated with Pluvicto and standard of care had a 38% […]